<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">human</item><item key="factors"><item><item key="GSE10971GSM277800"><item key="disease state">high grade serous carcinoma</item><item key="genotype">BRCA1/2 wildtype</item></item></item><item><item key="GSE10971GSM277809"><item key="disease state">high grade serous carcinoma</item><item key="genotype">BRCA1 3875delGTCT</item></item></item><item><item key="GSE10971GSM277812"><item key="disease state">high grade serous carcinoma</item><item key="genotype">BRCA1 mutation</item></item></item><item><item key="GSE10971GSM277801"><item key="disease state">high grade serous carcinoma</item><item key="genotype">Unknown</item></item></item><item><item key="GSE10971GSM277801"><item key="disease state">high grade serous carcinoma</item><item key="genotype">Unknown</item></item></item><item><item key="GSE10971GSM277801"><item key="disease state">high grade serous carcinoma</item><item key="genotype">Unknown</item></item></item><item><item key="GSE10971GSM277801"><item key="disease state">high grade serous carcinoma</item><item key="genotype">Unknown</item></item></item><item><item key="GSE10971GSM277801"><item key="disease state">high grade serous carcinoma</item><item key="genotype">Unknown</item></item></item><item><item key="GSE10971GSM277801"><item key="disease state">high grade serous carcinoma</item><item key="genotype">Unknown</item></item></item><item><item key="GSE10971GSM277812"><item key="disease state">high grade serous carcinoma</item><item key="genotype">BRCA1 mutation</item></item></item><item><item key="GSE10971GSM277812"><item key="disease state">high grade serous carcinoma</item><item key="genotype">BRCA1 mutation</item></item></item><item><item key="GSE10971GSM277801"><item key="disease state">high grade serous carcinoma</item><item key="genotype">Unknown</item></item></item><item><item key="GSE10971GSM277808"><item key="disease state">high grade serous carcinoma</item><item key="genotype">BRCA1 917delTT</item></item></item><item><item key="GSE10971GSM277788"><item key="disease state">normal</item><item key="genotype">BRCA1 5382insC</item></item></item><item><item key="GSE10971GSM277797"><item key="disease state">normal</item><item key="genotype">BRCA1 1293del40</item></item></item><item><item key="GSE10971GSM277798"><item key="disease state">normal</item><item key="genotype">BRCA1 185delAG</item></item></item><item><item key="GSE10971GSM277798"><item key="disease state">normal</item><item key="genotype">BRCA1 185delAG</item></item></item><item><item key="GSE10971GSM277798"><item key="disease state">normal</item><item key="genotype">BRCA1 185delAG</item></item></item><item><item key="GSE10971GSM277790"><item key="disease state">normal</item><item key="genotype">BRCA1 A1959T</item></item></item><item><item key="GSE10971GSM277798"><item key="disease state">normal</item><item key="genotype">BRCA1 185delAG</item></item></item><item><item key="GSE10971GSM277798"><item key="disease state">normal</item><item key="genotype">BRCA1 185delAG</item></item></item><item><item key="GSE10971GSM277793"><item key="disease state">normal</item><item key="genotype">BRCA2 C5910G</item></item></item><item><item key="GSE10971GSM277788"><item key="disease state">normal</item><item key="genotype">BRCA1 5382insC</item></item></item><item><item key="GSE10971GSM277798"><item key="disease state">normal</item><item key="genotype">BRCA1 185delAG</item></item></item><item><item key="GSE10971GSM277796"><item key="disease state">normal</item><item key="genotype">BRCA2 6174delT</item></item></item><item><item key="GSE10971GSM277776"><item key="disease state">normal</item><item key="genotype">not applicable</item></item></item><item><item key="GSE10971GSM277776"><item key="disease state">normal</item><item key="genotype">not applicable</item></item></item><item><item key="GSE10971GSM277776"><item key="disease state">normal</item><item key="genotype">not applicable</item></item></item><item><item key="GSE10971GSM277776"><item key="disease state">normal</item><item key="genotype">not applicable</item></item></item><item><item key="GSE10971GSM277776"><item key="disease state">normal</item><item key="genotype">not applicable</item></item></item><item><item key="GSE10971GSM277776"><item key="disease state">normal</item><item key="genotype">not applicable</item></item></item><item><item key="GSE10971GSM277776"><item key="disease state">normal</item><item key="genotype">not applicable</item></item></item><item><item key="GSE10971GSM277776"><item key="disease state">normal</item><item key="genotype">not applicable</item></item></item><item><item key="GSE10971GSM277776"><item key="disease state">normal</item><item key="genotype">not applicable</item></item></item><item><item key="GSE10971GSM277776"><item key="disease state">normal</item><item key="genotype">not applicable</item></item></item><item><item key="GSE10971GSM277776"><item key="disease state">normal</item><item key="genotype">not applicable</item></item></item><item><item key="GSE10971GSM277776"><item key="disease state">normal</item><item key="genotype">not applicable</item></item></item></item><item key="id">2836</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">The purpose of this study was to identify molecular alterations potentially involved in predisposition to adnexal serous carcinoma...</item><item key="pubmed_id">18593983</item><item key="geo_gse_id">E-GEOD-10971</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">2</item><item key="sample_count">37</item><item key="tags"><item>brca1</item><item>carcinoma</item><item>distal</item><item>serous carcinoma</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_id_plat">E-GEOD-10971_A-AFFY-44</item><item key="slug">transcription-profiling-by-array-of-human-non-mali</item><item key="geo_gds_id"/><item key="name">Transcription profiling by array of human non-malignant fallopian tube epithelium and high grade serous carcinoma</item><item key="created">Sep.03, 2014</item><item key="summary">The purpose of this study was to identify molecular alterations potentially involved in predisposition to adnexal serous carcinoma (SerCa) in the non-malignant fallopian tube epithelium   (FTE) of BRCA1/2-mutation carriers, given recent evidence implicating the distal FTE as a common source for SerCa. Experiment Overall Design: We obtained and compared gene expression profiles of laser capture microdissected non-malignant distal FTE from 12 known BRCA1/2-mutation carriers (FTEb) and 12 control women  (FTEn) during the luteal and follicular phase, as well as 13 high grade tubal and ovarian SerCa.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-10971</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-10971/samples/</item></data></biogps>
